Alzheimer's disease

Citations 31-40 of 576 total displayed.

Past content (since Jan 2001):

ARTICLES
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease

Alberto Pilotto, M. Franceschi, G. D’Onofrio, A. Bizzarro, F. Mangialasche, L. Cascavilla, F. Paris, M. G. Matera, Andrea Pilotto, A. Daniele, P. Mecocci, C. Masullo, B. Dallapiccola, and D. Seripa
Neurology 2009; 73: 761-767. [Abstract] [Full text] [PDF]  

ARTICLES
Systemic inflammation and disease progression in Alzheimer disease

C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, and V. H. Perry
Neurology 2009; 73: 768-774. [Abstract] [Full text] [PDF]  

ARTICLES
Follow-up of [¹¹C]PIB uptake and brain volume in patients with Alzheimer disease and controls

N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lötjönen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Någren, S. Helin, M. Scheinin, and J. O. Rinne
Neurology first published on September 2, 2009 as doi: WNL.0b013e3181bacf1b. [Abstract] Rapid PDF  

ARTICLES
The Nun Study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life

D. Iacono, W. R. Markesbery, M. Gross, O. Pletnikova, G. Rudow, P. Zandi, and J. C. Troncoso
Neurology 2009; 73: 665-673. [Abstract] [Full text] [PDF]  

ARTICLES
Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

Yan Deschaintre, Florence Richard, Didier Leys, and Florence Pasquier
Neurology 2009; 73: 674-680. [Abstract] [Full text] [PDF]  

ARTICLES
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels

P. van Vliet, R.G.J. Westendorp, P. Eikelenboom, H. C. Comijs, M. Frölich, E. Bakker, W. van der Flier, and E. van Exel
Neurology 2009; 73: 681-687. [Abstract] [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
AKINETOPSIA IN THE POSTERIOR CORTICAL VARIANT OF ALZHEIMER DISEASE

Po-Heng Tsai and Mario F. Mendez
Neurology 2009; 73: 731-732. [Full text] [PDF]  

ARTICLES
Neurocognitive contributions to verbal fluency deficits in frontotemporal lobar degeneration

D. J. Libon, C. McMillan, D. Gunawardena, C. Powers, L. Massimo, A. Khan, B. Morgan, C. Farag, L. Richmond, J. Weinstein, P. Moore, H. B. Coslett, A. Chatterjee, G. Aguirre, and M. Grossman
Neurology 2009; 73: 535-542. [Abstract] [Full text] [PDF]  

ARTICLES
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

C. R. McDonald, L. K. McEvoy, L. Gharapetian, C. Fennema-Notestine, D. J. Hagler, Jr, D. Holland, A. Koyama, J. B. Brewer, A. M. Dale For the Alzheimer’s Disease Neuroimaging Initiative
Neurology 2009; 73: 457-465. [Abstract] [Full text] [PDF]  

CLINICAL/SCIENTIFIC NOTES
16p11.2-RELATED PAROXYSMAL KINESIGENIC DYSKINESIA AND DOPA-RESPONSIVE PARKINSONISM IN A CHILD

Jonathan Lipton and Michael J. Rivkin
Neurology 2009; 73: 479-480. [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58